Literature DB >> 36075011

Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer.

Julia Schiantarelli1,2, Theodora Pappa1,2,3, Jake Conway1,2,4, Jett Crowdis1,2, Brendan Reardon1,2, Felix Dietlein1,2, Julian Huang5, Darren Stanizzi1, Evan Carey1, Alice Bosma-Moody1,2, Alma Imamovic1,2, Seunghun Han1,2,6, Sabrina Camp1,2, Eric Kofman7, Erin Shannon1,2, Justine A Barletta8, Meng Xiao He1,2,9, David Liu1,2, Jihye Park1,2, Jochen H Lorch1,10, Eliezer M Van Allen1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 36075011      PMCID： PMC9489159          DOI： 10.1200/PO.22.00183

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  25 in total

1.  Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors:  Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

2.  High-sensitivity BRAF mutation analysis: BRAF V600E is acquired early during tumor development but is heterogeneously distributed in a subset of papillary thyroid carcinomas.

Authors:  Dario de Biase; Valentina Cesari; Michela Visani; Gian Piero Casadei; Nadia Cremonini; Greta Gandolfi; Valentina Sancisi; Moira Ragazzi; Annalisa Pession; Alessia Ciarrocchi; Giovanni Tallini
Journal:  J Clin Endocrinol Metab       Date:  2014-04-29       Impact factor: 5.958

3.  Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study.

Authors:  Lene H S Veiga; Parveen Bhatti; Cécile M Ronckers; Alice J Sigurdson; Marilyn Stovall; Susan A Smith; Rita Weathers; Wendy Leisenring; Ann C Mertens; Sue Hammond; Joseph P Neglia; Anna T Meadows; Sarah S Donaldson; Charles A Sklar; Debra L Friedman; Leslie L Robison; Peter D Inskip
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

4.  High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas.

Authors:  Jennifer R Hess; Dorothee K Newbern; Kristen L Beebe; Alexandra M Walsh; Kristian T Schafernak
Journal:  Thyroid       Date:  2022-04       Impact factor: 6.568

5.  Lack of transgenerational effects of ionizing radiation exposure from the Chernobyl accident.

Authors:  Meredith Yeager; Mitchell J Machiela; Prachi Kothiyal; Michael Dean; Clara Bodelon; Shalabh Suman; Mingyi Wang; Lisa Mirabello; Chase W Nelson; Weiyin Zhou; Cameron Palmer; Bari Ballew; Leandro M Colli; Neal D Freedman; Casey Dagnall; Amy Hutchinson; Vibha Vij; Yosi Maruvka; Maureen Hatch; Iryna Illienko; Yuri Belayev; Nori Nakamura; Vadim Chumak; Elena Bakhanova; David Belyi; Victor Kryuchkov; Ivan Golovanov; Natalia Gudzenko; Elizabeth K Cahoon; Paul Albert; Vladimir Drozdovitch; Mark P Little; Kiyohiko Mabuchi; Chip Stewart; Gad Getz; Dimitry Bazyka; Amy Berrington de Gonzalez; Stephen J Chanock
Journal:  Science       Date:  2021-04-22       Impact factor: 63.714

6.  The mutational footprints of cancer therapies.

Authors:  Oriol Pich; Ferran Muiños; Martijn Paul Lolkema; Neeltje Steeghs; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Genet       Date:  2019-11-18       Impact factor: 38.330

7.  CoMut: visualizing integrated molecular information with comutation plots.

Authors:  Jett Crowdis; Meng Xiao He; Brendan Reardon; Eliezer M Van Allen
Journal:  Bioinformatics       Date:  2020-08-01       Impact factor: 6.937

8.  TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.

Authors:  Miguel Melo; Adriana Gaspar da Rocha; João Vinagre; Rui Batista; Joana Peixoto; Catarina Tavares; Ricardo Celestino; Ana Almeida; Catarina Salgado; Catarina Eloy; Patrícia Castro; Hugo Prazeres; Jorge Lima; Teresina Amaro; Cláudia Lobo; Maria João Martins; Margarida Moura; Branca Cavaco; Valeriano Leite; José Manuel Cameselle-Teijeiro; Francisco Carrilho; Manuela Carvalheiro; Valdemar Máximo; Manuel Sobrinho-Simões; Paula Soares
Journal:  J Clin Endocrinol Metab       Date:  2014-01-29       Impact factor: 5.958

9.  In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors.

Authors:  Arnoud Boot; Mi Ni Huang; Alvin W T Ng; Szu-Chi Ho; Jing Quan Lim; Yoshiiku Kawakami; Kazuaki Chayama; Bin Tean Teh; Hidewaki Nakagawa; Steven G Rozen
Journal:  Genome Res       Date:  2018-04-09       Impact factor: 9.043

10.  Cancer therapy shapes the fitness landscape of clonal hematopoiesis.

Authors:  Ryan N Ptashkin; Teng Gao; Ahmet Zehir; Elli Papaemmanuil; Kelly L Bolton; Lior Braunstein; Sean M Devlin; Daniel Kelly; Minal Patel; Antonin Berthon; Aijazuddin Syed; Mariko Yabe; Catherine C Coombs; Nicole M Caltabellotta; Mike Walsh; Kenneth Offit; Zsofia Stadler; Diana Mandelker; Jessica Schulman; Akshar Patel; John Philip; Elsa Bernard; Gunes Gundem; Juan E Arango Ossa; Max Levine; Juan S Medina Martinez; Noushin Farnoud; Dominik Glodzik; Sonya Li; Mark E Robson; Choonsik Lee; Paul D P Pharoah; Konrad H Stopsack; Barbara Spitzer; Simon Mantha; James Fagin; Laura Boucai; Christopher J Gibson; Benjamin L Ebert; Andrew L Young; Todd Druley; Koichi Takahashi; Nancy Gillis; Markus Ball; Eric Padron; David M Hyman; Jose Baselga; Larry Norton; Stuart Gardos; Virginia M Klimek; Howard Scher; Dean Bajorin; Eder Paraiso; Ryma Benayed; Maria E Arcila; Marc Ladanyi; David B Solit; Michael F Berger; Martin Tallman; Montserrat Garcia-Closas; Nilanjan Chatterjee; Luis A Diaz; Ross L Levine; Lindsay M Morton
Journal:  Nat Genet       Date:  2020-10-26       Impact factor: 41.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.